Detalhe da pesquisa
1.
Designing antibodies as therapeutics.
Cell
; 185(15): 2789-2805, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35868279
2.
Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagers.
Trends Immunol
; 43(11): 932-946, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36306739
3.
Potent antibody therapeutics by design.
Nat Rev Immunol
; 6(5): 343-57, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16622479
4.
Characterization of Chain Pairing Variants of Bispecific IgG Expressed in a Single Host Cell by High-Resolution Native and Denaturing Mass Spectrometry.
Anal Chem
; 88(24): 12122-12127, 2016 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193052
5.
Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG1 antibody.
MAbs
; 16(1): 2304282, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269489
6.
Introduction to current and future protein therapeutics: a protein engineering perspective.
Exp Cell Res
; 317(9): 1261-9, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21371474
7.
Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas.
Blood
; 113(18): 4352-61, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19147785
8.
Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies.
MAbs
; 12(1): 1692764, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31779513
9.
Data on charge separation of bispecific and mispaired IgGs using native charge-variant mass spectrometry.
Data Brief
; 30: 105435, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32274410
10.
Preclinical characterization of SGN-70, a humanized antibody directed against CD70.
Clin Cancer Res
; 14(23): 7763-72, 2008 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047103
11.
Anti-CD30 diabody-drug conjugates with potent antitumor activity.
Mol Cancer Ther
; 7(8): 2486-97, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18723494
12.
Engineered anti-CD70 antibody-drug conjugate with increased therapeutic index.
Mol Cancer Ther
; 7(9): 2913-23, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18790772
13.
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
MAbs
; 11(7): 1254-1265, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286843
14.
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties.
MAbs
; 11(2): 422-433, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550367
15.
Antibody targeting of B-cell maturation antigen on malignant plasma cells.
Mol Cancer Ther
; 6(11): 3009-18, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18025285
16.
Next generation antibody drugs: pursuit of the 'high-hanging fruit'.
Nat Rev Drug Discov
; 17(3): 197-223, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29192287
17.
Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97.
Mol Cancer Ther
; 5(6): 1474-82, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16818506
18.
Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more.
MAbs
; 9(6): 898-906, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28621572
19.
Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells.
MAbs
; 9(2): 213-230, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27929752
20.
Structural Analysis and Optimization of Context-Independent Anti-Hypusine Antibodies.
J Mol Biol
; 428(3): 603-617, 2016 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26778617